|
rs929783669
|
|
cervical cancer
|
|
0.700 |
GeneticVariation
|
UNIPROT |
|
|
|
|
rs121913483
|
|
cervical cancer
|
|
0.700 |
GeneticVariation
|
UNIPROT |
|
|
|
|
rs1058808
|
|
cervical cancer
|
|
0.010 |
GeneticVariation
|
BEFREE |
<b>Conclusions:</b> Our results suggested that the combination of <i>HER2</i> rs1136201and rs1058808 was significantly associated with the susceptibility of CCa.
|
30719131 |
2019 |
|
rs9277535
|
|
cervical cancer
|
|
0.720 |
GeneticVariation
|
BEFREE |
<i>Conclusion.</i> HLA-DP gene polymorphisms (HLA-DPB1⁎03:01, DPB1⁎04:02, DPB1⁎13:01, rs9277535, and rs3117027) were significantly associated with cervical cancer.
|
30009173 |
2018 |
|
rs3117027
|
|
cervical cancer
|
|
0.720 |
GeneticVariation
|
BEFREE |
<i>Conclusion.</i> HLA-DP gene polymorphisms (HLA-DPB1⁎03:01, DPB1⁎04:02, DPB1⁎13:01, rs9277535, and rs3117027) were significantly associated with cervical cancer.
|
30009173 |
2018 |
|
rs1048943
|
|
cervical cancer
|
|
0.090 |
GeneticVariation
|
BEFREE |
(2) rs1048943 (CYP1A1 A4889G) showed the strongest association with cervical cancer in the allele effect model (1.83[1.57, 2.13]); in addition, rs1048943 (CYP1A1 A4889G) had a very strong association in the dominant and recessive effect model.
|
25928231 |
2015 |
|
rs1217691063
|
|
cervical cancer
|
|
0.100 |
GeneticVariation
|
BEFREE |
Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis.
|
23070908 |
2013 |
|
rs1217691063
|
|
cervical cancer
|
|
0.100 |
GeneticVariation
|
BEFREE |
C677T polymorphism of MTHFR gene may increase the risk of cervical cancer in the complete over-dominant model.
|
23490201 |
2013 |
|
rs4646903
|
|
cervical cancer
|
|
0.050 |
GeneticVariation
|
BEFREE |
rs4646903 minor alleles and interaction between rs4646903 and rs1048943 were associated with increased cervical cancer risk.
|
27265845 |
2016 |
|
rs1292037
|
|
cervical cancer
|
|
0.010 |
GeneticVariation
|
BEFREE |
In addition to that, the G allele at rs1292037 (A > G) locus increases the risk of preoperative chemoresistance to cisplatin plus paclitaxel and is a poor prognostic factor for patients with CC.
|
30447706 |
2018 |
|
rs9277952
|
|
cervical cancer
|
|
0.720 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs9277535
|
|
cervical cancer
|
A |
0.720 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs9391756
|
|
cervical cancer
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs7770370
|
|
cervical cancer
|
A |
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs4713607
|
|
cervical cancer
|
A |
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs3129275
|
|
cervical cancer
|
A |
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs3117039
|
|
cervical cancer
|
A |
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs3117008
|
|
cervical cancer
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs213210
|
|
cervical cancer
|
T |
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs2116260
|
|
cervical cancer
|
T |
0.700 |
GeneticVariation
|
GWASDB |
A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12.
|
23817570 |
2013 |
|
rs3918242
|
|
cervical cancer
|
|
0.010 |
GeneticVariation
|
BEFREE |
A hospital-based case-control study was conducted in 230 patients with cervical cancer and 230 healthy controls to investigate the possible association between the MMP2 rs243865, MMP3 rs3025058, MMP7 rs11568818, and MMP9 rs3918242 polymorphisms, respectively, and the risk of cervical cancer.
|
26526578 |
2016 |
|
rs878854066
|
|
cervical cancer
|
|
0.100 |
GeneticVariation
|
BEFREE |
A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors.
|
25181402 |
2015 |
|
rs1131691014
|
|
cervical cancer
|
|
0.100 |
GeneticVariation
|
BEFREE |
A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors.
|
25181402 |
2015 |
|
rs1042522
|
|
cervical cancer
|
|
0.100 |
GeneticVariation
|
BEFREE |
A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors.
|
25181402 |
2015 |
|
rs1353702185
|
|
cervical cancer
|
|
0.010 |
GeneticVariation
|
BEFREE |
A hundred HIV-infected women were examined for HPV detection and its genotypes, as well as the frequencies of the SNPs Arg72Pro and SNP309 and their associations with CC risk factors.
|
25181402 |
2015 |